NCT02647853View on ClinicalTrials.gov

Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Nasolabial FoldsLipoatrophyLipodystrophy
Interventions
DRUG

TAT4 Gel concentration A

DRUG

TAT4 Gel concentration B

DRUG

Placebo

Trial Locations (1)

90630

Topokine Clinical Site, Cypress

All Listed Sponsors
lead

Topokine Therapeutics, Inc.

INDUSTRY

NCT02647853 - Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers | Biotech Hunter | Biotech Hunter